Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial

Thiazides and thiazide-type diuretics are recommended as first-line agents for the treatment of hypertension, but contemporary information on their use in clinical practice is lacking. We examined patterns and correlates of thiazide prescription in a cross-sectional analysis of baseline data from pa...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2016-03, Vol.67 (3), p.550-555
Main Authors: Chang, Tara I, Evans, Gregory, Cheung, Alfred K, Cushman, William C, Diamond, Matthew J, Dwyer, Jamie P, Huan, Yonghong, Kitzman, Dalane, Kostis, John B, Oparil, Suzanne, Rastogi, Anjay, Roumie, Christianne L, Sahay, Rukmani, Stafford, Randall S, Taylor, Addison A, Wright, Jackson T, Chertow, Glenn M
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Blood Pressure - drug effects
Blood Pressure - physiology
Cross-Sectional Studies
Female
Follow-Up Studies
Humans
Hypertension - drug therapy
Hypertension - physiopathology
Male
Middle Aged
Prescription Drugs
Retrospective Studies
Sodium Chloride Symporter Inhibitors - therapeutic use
Systole
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4771-db4561b28d60511af00d0b2ed34bc6a2b5809d03bb910f04af392845461b8cd3
cites cdi_FETCH-LOGICAL-c4771-db4561b28d60511af00d0b2ed34bc6a2b5809d03bb910f04af392845461b8cd3
container_end_page 555
container_issue 3
container_start_page 550
container_title Hypertension (Dallas, Tex. 1979)
container_volume 67
creator Chang, Tara I
Evans, Gregory
Cheung, Alfred K
Cushman, William C
Diamond, Matthew J
Dwyer, Jamie P
Huan, Yonghong
Kitzman, Dalane
Kostis, John B
Oparil, Suzanne
Rastogi, Anjay
Roumie, Christianne L
Sahay, Rukmani
Stafford, Randall S
Taylor, Addison A
Wright, Jackson T
Chertow, Glenn M
description Thiazides and thiazide-type diuretics are recommended as first-line agents for the treatment of hypertension, but contemporary information on their use in clinical practice is lacking. We examined patterns and correlates of thiazide prescription in a cross-sectional analysis of baseline data from participants enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT). We examined baseline prescription of thiazides in 7582 participants receiving at least 1 antihypertensive medication by subgroup, and used log-binomial regression to calculate adjusted prevalence ratios for thiazide prescription (versus no thiazide). Forty-three percent of all participants were prescribed a thiazide at baseline, but among participants prescribed a single agent, the proportion was only 16%. The prevalence of thiazide prescription differed significantly by demographic factors, with younger participants, women, and blacks all having higher adjusted prevalence of thiazide prescription than other corresponding subgroups. Participants in the lowest category of kidney function (estimated glomerular filtration rate
doi_str_mv 10.1161/HYPERTENSIONAHA.115.06851
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4755350</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1765118140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4771-db4561b28d60511af00d0b2ed34bc6a2b5809d03bb910f04af392845461b8cd3</originalsourceid><addsrcrecordid>eNqNkU9vEzEQxS0EoqHwFZC5cdli79r75wBSGgKJVLUR3QOcLO96ljU4drC9rcKnx01KBZw4WZr5zZs3fgi9ouSM0pK-WX3ZLD-1y8vr9dXlfDVPRX5GyprTR2hGec4yxsviMZoR2rCsofTzCXoWwjdCKGOseopO8rIueU7IDO03MkbwNmBpFV4478HICAG7AZ_LAEZbwO2o5U-tIGv3O8Dv9eQh6h5vPITe613UzmJtcRwBX-9DdCY1z41z6oCEhOO1TVtuwB7Y1mtpnqMngzQBXty_p6j9sGwXq-zi6uN6Mb_IelZVNFNdOoZ2ea1KwimVAyGKdDmognV9KfOO16RRpOi6hpKBMDkUTV4zztJQ3aviFL07yu6mbguqTxa8NGLn9Vb6vXBSi787Vo_iq7sRrOK84CQJvL4X8O7HBCGKrQ49GCMtuCkIWpXJV03ZHdoc0d67EDwMD2soEXfJiX-SS0UuDsml2Zd_-nyY_B1VAt4egVtn0l-G72a6BS9GkCaO_7HgF8FprWM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765118140</pqid></control><display><type>article</type><title>Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial</title><source>EZB Electronic Journals Library</source><creator>Chang, Tara I ; Evans, Gregory ; Cheung, Alfred K ; Cushman, William C ; Diamond, Matthew J ; Dwyer, Jamie P ; Huan, Yonghong ; Kitzman, Dalane ; Kostis, John B ; Oparil, Suzanne ; Rastogi, Anjay ; Roumie, Christianne L ; Sahay, Rukmani ; Stafford, Randall S ; Taylor, Addison A ; Wright, Jackson T ; Chertow, Glenn M</creator><creatorcontrib>Chang, Tara I ; Evans, Gregory ; Cheung, Alfred K ; Cushman, William C ; Diamond, Matthew J ; Dwyer, Jamie P ; Huan, Yonghong ; Kitzman, Dalane ; Kostis, John B ; Oparil, Suzanne ; Rastogi, Anjay ; Roumie, Christianne L ; Sahay, Rukmani ; Stafford, Randall S ; Taylor, Addison A ; Wright, Jackson T ; Chertow, Glenn M ; SPRINT Study Research Group</creatorcontrib><description>Thiazides and thiazide-type diuretics are recommended as first-line agents for the treatment of hypertension, but contemporary information on their use in clinical practice is lacking. We examined patterns and correlates of thiazide prescription in a cross-sectional analysis of baseline data from participants enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT). We examined baseline prescription of thiazides in 7582 participants receiving at least 1 antihypertensive medication by subgroup, and used log-binomial regression to calculate adjusted prevalence ratios for thiazide prescription (versus no thiazide). Forty-three percent of all participants were prescribed a thiazide at baseline, but among participants prescribed a single agent, the proportion was only 16%. The prevalence of thiazide prescription differed significantly by demographic factors, with younger participants, women, and blacks all having higher adjusted prevalence of thiazide prescription than other corresponding subgroups. Participants in the lowest category of kidney function (estimated glomerular filtration rate &lt;30 mL/min per 1.73 m2) were half as likely to be prescribed a thiazide as participants with preserved kidney function. In conclusion, among persons with hypertension and heightened cardiovascular risk, we found that thiazide prescription varied significantly by demographics and kidney disease status, despite limited evidence about relative differences in effectiveness.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.115.06851</identifier><identifier>PMID: 26865200</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Aged ; Aged, 80 and over ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Cross-Sectional Studies ; Female ; Follow-Up Studies ; Humans ; Hypertension - drug therapy ; Hypertension - physiopathology ; Male ; Middle Aged ; Prescription Drugs ; Retrospective Studies ; Sodium Chloride Symporter Inhibitors - therapeutic use ; Systole ; Treatment Outcome</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2016-03, Vol.67 (3), p.550-555</ispartof><rights>2016 American Heart Association, Inc</rights><rights>2016 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4771-db4561b28d60511af00d0b2ed34bc6a2b5809d03bb910f04af392845461b8cd3</citedby><cites>FETCH-LOGICAL-c4771-db4561b28d60511af00d0b2ed34bc6a2b5809d03bb910f04af392845461b8cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26865200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Tara I</creatorcontrib><creatorcontrib>Evans, Gregory</creatorcontrib><creatorcontrib>Cheung, Alfred K</creatorcontrib><creatorcontrib>Cushman, William C</creatorcontrib><creatorcontrib>Diamond, Matthew J</creatorcontrib><creatorcontrib>Dwyer, Jamie P</creatorcontrib><creatorcontrib>Huan, Yonghong</creatorcontrib><creatorcontrib>Kitzman, Dalane</creatorcontrib><creatorcontrib>Kostis, John B</creatorcontrib><creatorcontrib>Oparil, Suzanne</creatorcontrib><creatorcontrib>Rastogi, Anjay</creatorcontrib><creatorcontrib>Roumie, Christianne L</creatorcontrib><creatorcontrib>Sahay, Rukmani</creatorcontrib><creatorcontrib>Stafford, Randall S</creatorcontrib><creatorcontrib>Taylor, Addison A</creatorcontrib><creatorcontrib>Wright, Jackson T</creatorcontrib><creatorcontrib>Chertow, Glenn M</creatorcontrib><creatorcontrib>SPRINT Study Research Group</creatorcontrib><title>Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Thiazides and thiazide-type diuretics are recommended as first-line agents for the treatment of hypertension, but contemporary information on their use in clinical practice is lacking. We examined patterns and correlates of thiazide prescription in a cross-sectional analysis of baseline data from participants enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT). We examined baseline prescription of thiazides in 7582 participants receiving at least 1 antihypertensive medication by subgroup, and used log-binomial regression to calculate adjusted prevalence ratios for thiazide prescription (versus no thiazide). Forty-three percent of all participants were prescribed a thiazide at baseline, but among participants prescribed a single agent, the proportion was only 16%. The prevalence of thiazide prescription differed significantly by demographic factors, with younger participants, women, and blacks all having higher adjusted prevalence of thiazide prescription than other corresponding subgroups. Participants in the lowest category of kidney function (estimated glomerular filtration rate &lt;30 mL/min per 1.73 m2) were half as likely to be prescribed a thiazide as participants with preserved kidney function. In conclusion, among persons with hypertension and heightened cardiovascular risk, we found that thiazide prescription varied significantly by demographics and kidney disease status, despite limited evidence about relative differences in effectiveness.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prescription Drugs</subject><subject>Retrospective Studies</subject><subject>Sodium Chloride Symporter Inhibitors - therapeutic use</subject><subject>Systole</subject><subject>Treatment Outcome</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkU9vEzEQxS0EoqHwFZC5cdli79r75wBSGgKJVLUR3QOcLO96ljU4drC9rcKnx01KBZw4WZr5zZs3fgi9ouSM0pK-WX3ZLD-1y8vr9dXlfDVPRX5GyprTR2hGec4yxsviMZoR2rCsofTzCXoWwjdCKGOseopO8rIueU7IDO03MkbwNmBpFV4478HICAG7AZ_LAEZbwO2o5U-tIGv3O8Dv9eQh6h5vPITe613UzmJtcRwBX-9DdCY1z41z6oCEhOO1TVtuwB7Y1mtpnqMngzQBXty_p6j9sGwXq-zi6uN6Mb_IelZVNFNdOoZ2ea1KwimVAyGKdDmognV9KfOO16RRpOi6hpKBMDkUTV4zztJQ3aviFL07yu6mbguqTxa8NGLn9Vb6vXBSi787Vo_iq7sRrOK84CQJvL4X8O7HBCGKrQ49GCMtuCkIWpXJV03ZHdoc0d67EDwMD2soEXfJiX-SS0UuDsml2Zd_-nyY_B1VAt4egVtn0l-G72a6BS9GkCaO_7HgF8FprWM</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Chang, Tara I</creator><creator>Evans, Gregory</creator><creator>Cheung, Alfred K</creator><creator>Cushman, William C</creator><creator>Diamond, Matthew J</creator><creator>Dwyer, Jamie P</creator><creator>Huan, Yonghong</creator><creator>Kitzman, Dalane</creator><creator>Kostis, John B</creator><creator>Oparil, Suzanne</creator><creator>Rastogi, Anjay</creator><creator>Roumie, Christianne L</creator><creator>Sahay, Rukmani</creator><creator>Stafford, Randall S</creator><creator>Taylor, Addison A</creator><creator>Wright, Jackson T</creator><creator>Chertow, Glenn M</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201603</creationdate><title>Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial</title><author>Chang, Tara I ; Evans, Gregory ; Cheung, Alfred K ; Cushman, William C ; Diamond, Matthew J ; Dwyer, Jamie P ; Huan, Yonghong ; Kitzman, Dalane ; Kostis, John B ; Oparil, Suzanne ; Rastogi, Anjay ; Roumie, Christianne L ; Sahay, Rukmani ; Stafford, Randall S ; Taylor, Addison A ; Wright, Jackson T ; Chertow, Glenn M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4771-db4561b28d60511af00d0b2ed34bc6a2b5809d03bb910f04af392845461b8cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prescription Drugs</topic><topic>Retrospective Studies</topic><topic>Sodium Chloride Symporter Inhibitors - therapeutic use</topic><topic>Systole</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Tara I</creatorcontrib><creatorcontrib>Evans, Gregory</creatorcontrib><creatorcontrib>Cheung, Alfred K</creatorcontrib><creatorcontrib>Cushman, William C</creatorcontrib><creatorcontrib>Diamond, Matthew J</creatorcontrib><creatorcontrib>Dwyer, Jamie P</creatorcontrib><creatorcontrib>Huan, Yonghong</creatorcontrib><creatorcontrib>Kitzman, Dalane</creatorcontrib><creatorcontrib>Kostis, John B</creatorcontrib><creatorcontrib>Oparil, Suzanne</creatorcontrib><creatorcontrib>Rastogi, Anjay</creatorcontrib><creatorcontrib>Roumie, Christianne L</creatorcontrib><creatorcontrib>Sahay, Rukmani</creatorcontrib><creatorcontrib>Stafford, Randall S</creatorcontrib><creatorcontrib>Taylor, Addison A</creatorcontrib><creatorcontrib>Wright, Jackson T</creatorcontrib><creatorcontrib>Chertow, Glenn M</creatorcontrib><creatorcontrib>SPRINT Study Research Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Tara I</au><au>Evans, Gregory</au><au>Cheung, Alfred K</au><au>Cushman, William C</au><au>Diamond, Matthew J</au><au>Dwyer, Jamie P</au><au>Huan, Yonghong</au><au>Kitzman, Dalane</au><au>Kostis, John B</au><au>Oparil, Suzanne</au><au>Rastogi, Anjay</au><au>Roumie, Christianne L</au><au>Sahay, Rukmani</au><au>Stafford, Randall S</au><au>Taylor, Addison A</au><au>Wright, Jackson T</au><au>Chertow, Glenn M</au><aucorp>SPRINT Study Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2016-03</date><risdate>2016</risdate><volume>67</volume><issue>3</issue><spage>550</spage><epage>555</epage><pages>550-555</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><abstract>Thiazides and thiazide-type diuretics are recommended as first-line agents for the treatment of hypertension, but contemporary information on their use in clinical practice is lacking. We examined patterns and correlates of thiazide prescription in a cross-sectional analysis of baseline data from participants enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT). We examined baseline prescription of thiazides in 7582 participants receiving at least 1 antihypertensive medication by subgroup, and used log-binomial regression to calculate adjusted prevalence ratios for thiazide prescription (versus no thiazide). Forty-three percent of all participants were prescribed a thiazide at baseline, but among participants prescribed a single agent, the proportion was only 16%. The prevalence of thiazide prescription differed significantly by demographic factors, with younger participants, women, and blacks all having higher adjusted prevalence of thiazide prescription than other corresponding subgroups. Participants in the lowest category of kidney function (estimated glomerular filtration rate &lt;30 mL/min per 1.73 m2) were half as likely to be prescribed a thiazide as participants with preserved kidney function. In conclusion, among persons with hypertension and heightened cardiovascular risk, we found that thiazide prescription varied significantly by demographics and kidney disease status, despite limited evidence about relative differences in effectiveness.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>26865200</pmid><doi>10.1161/HYPERTENSIONAHA.115.06851</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2016-03, Vol.67 (3), p.550-555
issn 0194-911X
1524-4563
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4755350
source EZB Electronic Journals Library
subjects Aged
Aged, 80 and over
Blood Pressure - drug effects
Blood Pressure - physiology
Cross-Sectional Studies
Female
Follow-Up Studies
Humans
Hypertension - drug therapy
Hypertension - physiopathology
Male
Middle Aged
Prescription Drugs
Retrospective Studies
Sodium Chloride Symporter Inhibitors - therapeutic use
Systole
Treatment Outcome
title Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A59%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patterns%20and%20Correlates%20of%20Baseline%20Thiazide-Type%20Diuretic%20Prescription%20in%20the%20Systolic%20Blood%20Pressure%20Intervention%20Trial&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Chang,%20Tara%20I&rft.aucorp=SPRINT%20Study%20Research%20Group&rft.date=2016-03&rft.volume=67&rft.issue=3&rft.spage=550&rft.epage=555&rft.pages=550-555&rft.issn=0194-911X&rft.eissn=1524-4563&rft_id=info:doi/10.1161/HYPERTENSIONAHA.115.06851&rft_dat=%3Cproquest_pubme%3E1765118140%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4771-db4561b28d60511af00d0b2ed34bc6a2b5809d03bb910f04af392845461b8cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1765118140&rft_id=info:pmid/26865200&rfr_iscdi=true